A Selective Nav1.8 Sodium Channel Blocker, A-803467 [5-(4-Chlorophenyl-N-(3,5-dimethoxyphenyl)furan-2-carboxamide], Attenuates Spinal Neuronal Activity in Neuropathic Rats

We have recently reported that systemic delivery of A-803467 [5-(4-chlorophenyl-N-(3,5-dimethoxyphenyl)furan-2-carboxamide], a selective Nav1.8 sodium channel blocker, reduces behavioral measures of chronic pain. In the current study, the effects of A-803467 on evoked and spontaneous firing of wide dynamic range (WDR) neurons were measured in uninjured and rats with spinal nerve ligations (SNLs). Administration of A-803467 (10–30 mg/kg i.v.) reduced mechanically evoked (10-g von Frey hair) and spontaneous WDR neuronal activity in SNL rats. In uninjured rats, A-803467 (20 mg/kg i.v.) transiently reduced evoked but not spontaneous firing of WDR neurons. The systemic effects of A-803467 in SNL rats were not altered by spinal transection or by systemic pretreatment with the transient receptor potential vanilloid type 1 (TRPV1) receptor agonist, resiniferatoxin, at doses that impair the function of TRPV1-expressing fibers. To determine sites of action, A-803467 was administered into spinal tissue, into the uninjured L4 dorsal root ganglion (DRG), or into the neuronal receptive field. Injections of A-803467 into the L4 DRG (30–100 nmol/1 μl) or into the hindpaw receptive field (300 nmol/50 μl) reduced evoked but not spontaneous WDR firing. In contrast, intraspinal (50–150 nmol/0.5 μl) injection of A-803467 decreased both evoked and spontaneous discharges of WDR neurons. Thus, Nav1.8 sodium channels on the cell bodies/axons within the L4 DRG as well as on peripheral and central terminals of primary afferent neurons regulate the inflow of low-intensity mechanical signals to spinal WDR neurons. However, Nav1.8 sodium channels on central terminals seem to be key to the modulation of spontaneous firing in SNL rats.

[1]  D. Donnelly-roberts,et al.  P2X7-related modulation of pathological nociception in rats , 2007, Neuroscience.

[2]  T. Richardson,et al.  Potentiation of spinal α2-adrenoceptor analgesia in rats deficient in TRPV1-expressing afferent neurons , 2007, Neuropharmacology.

[3]  Matthew S. Johnson,et al.  A-803467, a potent and selective Nav1.8 sodium channel blocker, attenuates neuropathic and inflammatory pain in the rat , 2007, Proceedings of the National Academy of Sciences.

[4]  K. Park,et al.  The role of uninjured C-afferents and injured afferents in the generation of mechanical hypersensitivity after partial peripheral nerve injury in the rat , 2007, Experimental Neurology.

[5]  David John Adams,et al.  μO-conotoxin MrVIB selectively blocks Nav1.8 sensory neuron specific sodium channels and chronic pain behavior without motor deficits , 2006, Proceedings of the National Academy of Sciences.

[6]  E. Stevens,et al.  The role of sodium channels in neuropathic pain. , 2006, Seminars in cell & developmental biology.

[7]  J. Sullivan,et al.  Involvement of the TTX-resistant sodium channel Nav 1.8 in inflammatory and neuropathic, but not post-operative, pain states , 2006, Pain.

[8]  Manabu Itoh,et al.  Potent analgesic effects of a putative sodium channel blocker M58373 on formalin-induced and neuropathic pain in rats. , 2006, European journal of pharmacology.

[9]  A. Dickenson,et al.  Differential pharmacological modulation of the spontaneous stimulus-independent activity in the rat spinal cord following peripheral nerve injury , 2006, Experimental Neurology.

[10]  O. McManus,et al.  Block of Peripheral Nerve Sodium Channels Selectively Inhibits Features of Neuropathic Pain in Rats , 2006, Molecular Pharmacology.

[11]  A. Dickenson,et al.  Nav 1.8-null mice show stimulus-dependent deficits in spinal neuronal activity , 2006, Molecular pain.

[12]  M. Jarvis,et al.  Systemic and site-specific effects of A-425619, a selective TRPV1 receptor antagonist, on wide dynamic range neurons in CFA-treated and uninjured rats. , 2006, Journal of neurophysiology.

[13]  J. Chung,et al.  Mechanical and heat sensitization of cutaneous nociceptors in rats with experimental peripheral neuropathy , 2005, Neuroscience.

[14]  K. Arndt,et al.  Ambroxol, a Nav1.8-preferring Na+ channel blocker, effectively suppresses pain symptoms in animal models of chronic, neuropathic and inflammatory pain , 2005, Neuropharmacology.

[15]  Peter Jonas,et al.  Presynaptic Action Potential Amplification by Voltage-Gated Na+ Channels in Hippocampal Mossy Fiber Boutons , 2005, Neuron.

[16]  M. Jarvis,et al.  Increased WDR spontaneous activity and receptive field size in rats following a neuropathic or inflammatory injury: implications for mechanical sensitivity , 2004, Neuroscience Letters.

[17]  W. Fu,et al.  Inhibition of neuropathic pain by a potent disintegrin—triflavin , 2004, Neuroscience Letters.

[18]  L. Djouhri,et al.  The TTX‐Resistant Sodium Channel Nav1.8 (SNS/PN3): Expression and Correlation with Membrane Properties in Rat Nociceptive Primary Afferent Neurons , 2003, The Journal of physiology.

[19]  M. Jarvis,et al.  Distinct neurochemical mechanisms are activated following administration of different P2X receptor agonists into the hindpaw of a rat , 2003, Brain Research.

[20]  R. Maj,et al.  Anti-allodynic effect of NW-1029, a novel Na+ channel blocker, in experimental animal models of inflammatory and neuropathic pain , 2003, Pain.

[21]  D. Weinreich,et al.  Redistribution of NaV1.8 in Uninjured Axons Enables Neuropathic Pain , 2003, The Journal of Neuroscience.

[22]  S. Dib-Hajj,et al.  Na(v)1.5 underlies the 'third TTX-R sodium current' in rat small DRG neurons. , 2002, Brain research. Molecular brain research.

[23]  M. Gold,et al.  Inhibition of neuropathic pain by decreased expression of the tetrodotoxin-resistant sodium channel, NaV1.8 , 2002, Pain.

[24]  M. Iadarola,et al.  Ligand-induced Dynamic Membrane Changes and Cell Deletion Conferred by Vanilloid Receptor 1* , 2001, The Journal of Biological Chemistry.

[25]  J. Mao,et al.  Systemic lidocaine for neuropathic pain relief , 2000, Pain.

[26]  R. Meyer,et al.  Mechanical hyperalgesia after an L5 spinal nerve lesion in the rat is not dependent on input from injured nerve fibers , 2000, Pain.

[27]  C. Woolf,et al.  Diversity of Expression of the Sensory Neuron-Specific TTX-Resistant Voltage-Gated Sodium Ion Channels SNS and SNS2 , 2000, Molecular and Cellular Neuroscience.

[28]  M. Biella.  Contribution of central sensitization to the pain-related abnormal activity in neuropathic rats , 2000, Somatosensory & motor research.

[29]  S. Dib-Hajj,et al.  Sodium channels, excitability of primary sensory neurons, and the molecular basis of pain , 1999, Muscle & nerve.

[30]  R M Eglen,et al.  A comparison of the potential role of the tetrodotoxin-insensitive sodium channels, PN3/SNS and NaN/SNS2, in rat models of chronic pain. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[31]  S. Boyce,et al.  The tetrodotoxin-resistant sodium channel SNS has a specialized function in pain pathways , 1999, Nature Neuroscience.

[32]  A. Dickenson,et al.  Electrophysiological characterization of spinal neuronal response properties in anaesthetized rats after ligation of spinal nerves L5‐L6 , 1998, The Journal of physiology.

[33]  T. Hökfelt,et al.  Effects of the capsaicin analogue resiniferatoxin on spinal nociceptive mechanisms in the rat: behavioral, electrophysiological and in situ hybridization studies , 1997, Brain Research.

[34]  S. Dib-Hajj,et al.  Spinal sensory neurons express multiple sodium channel α-subunit mRNAs , 1996 .

[35]  L. Sivilotti,et al.  A tetrodotoxin-resistant voltage-gated sodium channel expressed by sensory neurons , 1996, Nature.

[36]  S. Dib-Hajj,et al.  Spinal sensory neurons express multiple sodium channel alpha-subunit mRNAs. , 1996, Brain research. Molecular brain research.

[37]  S L Shafer,et al.  Prolonged Alleviation of Tactile Allodynia by Intravenous Lidocaine in Neuropathic Rats , 1995, Anesthesiology.

[38]  S. Waxman,et al.  Type III sodium channel mRNA is expressed in embryonic but not adult spinal sensory neurons, and is reexpressed following axotomy. , 1994, Journal of neurophysiology.

[39]  M. L. Sotgiu,et al.  Effect of systemic lidocaine on dorsal horn neuron hyperactivity following chronic peripheral nerve injury in rats. , 1992, Somatosensory & motor research.

[40]  J. Kastrup,et al.  The effect of intravenous lidocaine on nociceptive processing in diabetic neuropathy , 1990, Pain.

[41]  F. Joó,et al.  Duration of desensitization and ultrastructural changes in dorsal root ganglia in rats treated with resiniferatoxin, an ultrapotent capsaicin analog , 1989, Brain Research.

[42]  J. Kastrup,et al.  Chronic pain treatment with intravenous lidocaine. , 1986, Neurological research.